Molecular Diagnostics Market CAGR To be Around 6.2% by 2035, Due to the Growing Demand for Personalized Healthcare| Roots Analysis

According to our latest market report "Molecular Diagnostics Market: Industry Trends and Global Forecasts, till 2035 by Test Type, Type of Offering, Type of Sample, Type of Technology, Therapeutic Area, End Users and Geographical Regions", the global molecular diagnostics market size is projected to reach USD 30.9 billion by 2035 from USD 15.9 billion in 2024, growing at a CAGR of 6.2% in the forecast period 2024-2035.

Molecular diagnostic tests refer to tests intended to detect specific sequences in human genomic samples, such as DNA or RNA, in order to diagnose a particular disease. Further, such tests also aim to identify single nucleotide polymorphisms, deletions, rearrangements, and insertions in genetic sequences. It is worth mentioning that molecular diagnostics is a subset of the broader in vitro diagnostics market. The common types of molecular diagnostic tests include PCR, RT-PCR, DNA microarrays and next generation sequencing tests. Such tests play a crucial role in healthcare by providing timely and accurate information for medical decision-making. molecular diagnostic solutions are essential tools for screening, diagnosing, and monitoring diseases, ultimately contributing to improved patient outcomes and public health.

To request quote of this report, please visit: https://www.rootsanalysis.com/reports/molecular-diagnostics-market/request-quote.html

Molecular Diagnostics Market Segments
Based on test type, the market is segmented into laboratory and point-of-care testing.
1. The laboratory testing segment led the molecular diagnostics market, capturing the largest revenue share of 85% in 2024.
2. The point-of-care segment is anticipated to show the highest annual growth rate of 9.1% during the forecast period.

Based on the type of offering, the market is segmented into reagents, instruments, and services.
1. The reagents segment led the molecular diagnostics market, capturing the largest revenue share of 70% in 2024.
2. Owing to the intricacies and complexities associated with the development of molecular diagnostic solutions, this trend is expected to remain the same during the forecast period.

Based on the type of sample, the market is segmented into blood / serum / plasma, urine, and other samples.

1. The blood, serum and plasma segment led the molecular diagnostics market, capturing the largest revenue share of 77% in 2024.
2. Owing to its widespread use in detecting infectious disease, cancer biomarkers, and genetic conditions.

Based on type of technology, the market is segmented into PCR, in situ hybridization, isothermal nucleic acid amplification technology, next generation sequencing, microarrays, mass spectrometry and others.

1. The PCR technology segment led the molecular diagnostics market, capturing the largest revenue share of 41% in 2024.
2. The next generation sequencing is anticipated to show the highest annual growth rate of 7.3% during the forecast period.

Based on therapeutic areas, the market is segmented into cardiovascular diseases, genetic diseases, infectious diseases, neurological disease, oncological disorders and others.

1. The infectious disease segment led the molecular diagnostics market, capturing the largest revenue share of 42.8% in 2024.
2. The neurological segment is anticipated to show the highest annual growth rate of 6.9%, during the forecast period.

Based on end users, the market is segmented into hospitals, laboratories, and other end users.

1. The hospitals segment led the molecular diagnostics market, capturing the largest revenue share of 48% in 2024.
2. The hospitals segment is anticipated to show an annual growth rate of 6.5% during the forecast period and is expected to hold the majority share of the market in the future, as well.

Based on geographical regions, the market is segmented into North America, Europe, Asia, Latin America, Middle East and North Africa, and Rest of the World

1. North America dominated the molecular diagnostics market and accounted for the largest revenue share of 38.9 % in 2024.
2. In Asia, the molecular diagnostics market is anticipated to demonstrate lucrative growth during the forecast period.

Molecular Diagnostics Market Regional Outlook
Based on the key geographical regions, the molecular diagnostics market can be segmented into three major regions, including North America, Europe, Asia-Pacific and rest of the world. Led by the US, North America is anticipated to capture the majority share of the Molecular Diagnostics Market in 2024 and this trend is likely to remain unchanged during the forecast period. Further, the demand for molecular diagnostic solutions is growing at a faster rate in Asia, owing to the increasing government initiatives in developing countries. The government is encouraging solution providers to develop molecular diagnostic solutions in order to cater to the growing burden of patients suffering from illnesses.

Key Report Takeaways
1. The molecular diagnostics market landscape is well distributed among leading players that utilize various types of advanced diagnostic technologies in order to cater to a variety of diagnostic applications
2. Majority of the molecular diagnostic solutions employ the use of PCR technologies in order to detect and diagnose various disease conditions, such as infectious diseases and oncological disorders
3. Industry players are making extensive efforts to expand their existing capacities, capabilities and facilities to augment their molecular diagnostic solutions portfolio
4. Molecular diagnostics is a well-established market wherein the solution providers are currently focusing on innovation and technological advancements to enhance diagnostic accuracy, speed, and accessibility
5. The molecular diagnostics market is fueled by growing awareness towards preventive healthcare, however factors, such as addressing regulatory complexities remain significant hurdles for industry players
6. Driven by the increasing prevalence of chronic disorders across the globe, we anticipate the global molecular diagnostics market is expected to reach nearly USD 30.9 billion by 2035
7. The anticipated future opportunity in the molecular diagnostics market, is expected to be well distributed across multiple segments, such as therapeutic areas, test type and end users

Browse Full Report Description + Research Methodology + Table of Content + Infographics here: https://www.rootsanalysis.com/reports/molecular-diagnostics-market.html

Molecular Diagnostics Market Key Players
Examples of key companies engaged in the Molecular Diagnostics Market (which have also been profiled in this market report; the complete list of companies is available in the full report) include, Abbott Laboratories, Agilent Technologies, Becton Dickinson, BGI Genomics, bioMérieux, Bio-Rad, Danaher, DiaSorin, Grifols, Hologic, Illumina, Qiagen, QuidelOrtho, Revvity, Roche, Sansure, Seegene, Siemens Healthineers, Sysmex and Thermo Fisher Scientific.

Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.